All Pharma News
Psyence Biomedical Partners with Fluence

Psyence Biomedical Partners with Fluence
GLOBENEWSWIRE
16 Apr 2024
Share Share
Psyence Welcomes Results of Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin

Psyence Welcomes Results of Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
GLOBENEWSWIRE
18 Mar 2024
Share Share
Psyence Receives Nasdaq Notifications Regarding Market Value of Securities

Psyence Receives Nasdaq Notifications Regarding Market Value of Securities
GLOBENEWSWIRE
15 Mar 2024
Share Share
Psyence Issues Shareholder Letter Recapping Recent Progress

Psyence Issues Shareholder Letter Recapping Recent Progress
GLOBENEWSWIRE
12 Mar 2024
Share Share
Psyence Biomedical, Receives Approval to Initiate Phase IIb Study

Psyence Biomedical, Receives Approval to Initiate Phase IIb Study
GLOBENEWSWIRE
12 Mar 2024
Share Share
Psyence Biomedical Ltd. Approved to List on Nasdaq

Psyence Biomedical Ltd. Approved to List on Nasdaq
GLOBENEWSWIRE
25 Jan 2024
Share Share
Psyence announces signing of definitive agreement for a convertible note

Psyence announces signing of definitive agreement for a convertible note
GLOBENEWSWIRE
16 Jan 2024
Share Share
Psyence Production Expands Capability

Psyence Production Expands Capability
GLOBENEWSWIRE
30 Oct 2023
Share Share
Psyence Announces Closing of Private Placement & Conclusion of Loan Agreement

Psyence Announces Closing of Private Placement & Conclusion of Loan Agreement
GLOBENEWSWIRE
21 Aug 2023
Share Share
Psyence Group Announces SEC Registration Filing with NASDAQ SPAC

Psyence Group Announces SEC Registration Filing with NASDAQ SPAC
GLOBENEWSWIRE
02 Aug 2023
Share Share